Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 406 AL 420

Beyond Neuroinflammation: Microglia at the Crossroads of Amyloid, Tau, and Neurodegeneration in Alzheimer's Disease

Ebrahimi R, Bordbar S, Azad G, Davoody S, Mahmoudi M, Esmaeilpour K.

Neurol Sci. 2025 Nov;46(11):5591-5605. doi: 10.1007/s10072-025-08403-4. Epub 2025 Aug 19.

The Crosstalk Between Protective and Detrimental Interleukin (IL)-1 Family of Cytokines in Alzheimer's Disease

Liu T, Li X.

J Biochem Mol Toxicol. 2025 Sep;39(9):e70460. doi: 10.1002/jbt.70460.

The emerging role of disulfidptosis in Alzheimer's disease

Zhou Q, Zheng N, Chen Z, Xie L, Yang X, Sun Q, Lin J, Li B, Li L.

Eur J Pharmacol. 2025 Oct 15;1005:178085. doi: 10.1016/j.ejphar.2025.178085. Epub 2025 Aug 21.

Tau and Amyloid beta causes microglial activation in Alzheimer's disease

Chinnathambi S, Adithyan A, Chandrashekar M, Rangappa N.

Adv Clin Chem. 2025;128:83-107. doi: 10.1016/bs.acc.2025.06.002. Epub 2025 Jul 11.

Copper homeostasis and cuproptosis in Alzheimer's disease (Review)

Cong C, Cong H, Yao Y, Bai Y, Xu L.

Int J Mol Med. 2025 Nov;56(5):172. doi: 10.3892/ijmm.2025.5613. Epub 2025 Aug 24.

Cell-specific copper dyshomeostasis mechanism in Alzheimer's disease

Okafor M, Faller P, Vitale N.

Transl Neurodegener. 2025 Aug 22;14(1):42. doi: 10.1186/s40035-025-00504-6.

Digital Tools for People Without an Alzheimer Disease or Dementia Diagnosis: Scoping Review

de Rijke TJ, Engelsma T, Ng CH, Kaijser KK, Nap HH, Smets EM, Visser LN.

J Med Internet Res. 2025 Aug 25;27:e64862. doi: 10.2196/64862.

Cannabidiol and Alzheimer Disease: A Comprehensive Review and In Silico Insights Into Molecular Interactions

Mello-Hortega JV, de Oliveira CS, de Araujo VS, Furtado-Alle L, Tureck LV, Souza RLR.

Eur J Neurosci. 2025 Aug;62(4):e70229. doi: 10.1111/ejn.70229.

Insights into CYP450 polymorphisms and their impact on drug metabolism in Alzheimer's disease therapy

Zheng J, Liu G, Wang Q, Liang Y.

Drug Metab Rev. 2025 Nov;57(4):523-534. doi: 10.1080/03602532.2025.2552786. Epub 2025 Sep 3.

Membrane-Type 5 Matrix Metalloproteinase (MT5-MMP): Background and Proposed Roles in Normal Physiology and Disease

Jadhav D, Knapinska AM, Wang H, Fields GB.

Biomolecules. 2025 Aug 3;15(8):1114. doi: 10.3390/biom15081114.

Rodent models of Alzheimer's disease: Critical analysis of current hypotheses and pathways for future research

Singhaarachchi PH, Antal P, Calon F, Culmsee C, Delpech JC, Feldotto M, Geertsema J, Hoeksema EE, Korosi A, Layé S, McQualter J, de Rooij SR, Rummel C, Slayo M, Sominsky L, Spencer SJ.

Prog Neurobiol. 2025 Sep;252:102821. doi: 10.1016/j.pneurobio.2025.102821. Epub 2025 Aug 29.

[Aβ Receptor PirB and its regulation by LOTUS]

Kawaguchi Y, Takei K.

Nihon Yakurigaku Zasshi. 2025;160(5):318-323. doi: 10.1254/fpj.25018.

Hydrogen sulfide in the brain as a silent neuroprotector in Alzheimer's disease

Layal H, Rajbongshi J, Kumar R, Pandey S, Mishra R, Yadav PK.

Neuroscience. 2025 Oct 15;585:181-197. doi: 10.1016/j.neuroscience.2025.08.057. Epub 2025 Sep 2.

[Anti-amyloid antibodies for the treatment of early-stage Alzheimer's disease]

Frederiksen KS, Gramkow MH, Hasselbalch SG, Law I, Waldemar G.

Ugeskr Laeger. 2025 Aug 25;187(35):V03250217. doi: 10.61409/V03250217.

Exploring LRP-1 in the liver-brain axis: implications for Alzheimer's disease

Sharma VK.

Mol Biol Rep. 2025 Sep 8;52(1):873. doi: 10.1007/s11033-025-10980-8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias